10 Earnings to Watch Monday
6. Pernix Therapeutics Holdings (PTX) a specialty pharmaceutical company, is mainly focused on developing and commercializing pharmaceutical products in order to meet unmet medical needs primarily in pediatrics. Through a combination of internal development, acquisition and in-licensing activities, the company develops and promotes its products in almost 30 states.
Net income for the first quarter 2011 is forecast at $1.99 million on sales of $8.5 million, compared to net income of $1.49 million on $12.2 million sales recorded during 2010 fourth quarter, according to analysts polled by Bloomberg. Earnings per share are seen at 10 cents for the quarter, up from 6 cents per share reported during fourth quarter of 2010.
Both the analysts covering the stock recommend a buy rating on it. There are no sell ratings on the stock. Analysts polled by Bloomberg expect the stock to gain an average 65.3% to $20.5 in value from current levels.
Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
TheStreet Quant Ratings
TRY IT FREENew! $49.95/yr
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
Product Features:
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Dividend Stock Advisor
TRY IT FREEJim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
